Skip to main content
Collin Blakely, MD, Oncology, San Francisco, CA

CollinBlakelyMDPh.D.

Oncology • San Francisco, CA

Hematologic Oncology, Thoracic Cancer

Clinical Instructor, Internal Medicine, UCSF School of Medicine

Join to view full profile

Dr. Blakely is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Blakely's full profile

Already have an account?

  • Office

    505 Parnassus Ave
    San Francisco, CA 94143
    Phone+1 415-885-7276
    Fax+1 415-353-9615

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2009 - 2011
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Internal Medicine, 2007 - 2009
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 2007

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2009 - 2026
  • PA State Medical License
    PA State Medical License 2007 - 2009
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Aurora Kinase A Drives the Evolution of Resistance to Third-Generation EGFR Inhibitors in Lung Cancer  
    Victoria E Wang, Collin M Blakely, Trever G Bivona, Andrei Goga, Nature
  • Pathologic Complete Response to Neoadjuvant Crizotinib in a Lung Adenocarcinoma Patient with a MET Exon 14 Skipping Mutation  
    Julia K Rotow, Trever G Bivona, Collin M Blakely, Clinical Lung Cancer

Authored Content

  • Pathologic Complete Response to Neoadjuvant Crizotinib in a Lung Adenocarcinoma Patient with a MET Exon 14 Skipping MutationNovember 2018

Press Mentions

  • Damon Runyon Cancer Research Foundation Awards $4.8 Million to Rising Investigators
    Damon Runyon Cancer Research Foundation Awards $4.8 Million to Rising InvestigatorsJuly 15th, 2021
  • Deadly Lung Cancers Are Driven by Multiple Genetic Changes
    Deadly Lung Cancers Are Driven by Multiple Genetic ChangesNovember 6th, 2017
  • Deadly Lung Cancers Are Driven by Multiple Genetic Changes
    Deadly Lung Cancers Are Driven by Multiple Genetic ChangesNovember 6th, 2017
  • Join now to see all

Dr. Collin Blakely, Dr. Collin Blakely, MD, Dr. C Blakely